Routine cerebrospinal fluid (CSF) parameters in patients with spinal muscular atrophy (SMA) treated with nusinersen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Neurology ; 10 (2019). - Art.-Nr. 1179. - eISSN 1664-2295
- Keyword
-
Spinale Muskelatrophie
Multiple Sklerose
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2019
- Creator
-
Koch, Jan C.
Cordts, Isabell
Dreyhaupt, Jens
Otto, Markus
Uzelac, Zeljko
Witzel, Simon
Winter, Benedikt
Kocak, Tugrul
Schocke, Michael
Weydt, Patrick
Wollinsky, Kurt
Ludolph, Albert C.
Deschauer, Marcus
Lingor, Paul
Tumani, Hayrettin
Hermann, Andreas
Günther, René
Wurster, Claudia D.
- DOI
-
10.18725/OPARU-38822
- URN
-
urn:nbn:de:bsz:289-oparu-38898-6
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koch, Jan C.
- Cordts, Isabell
- Dreyhaupt, Jens
- Otto, Markus
- Uzelac, Zeljko
- Witzel, Simon
- Winter, Benedikt
- Kocak, Tugrul
- Schocke, Michael
- Weydt, Patrick
- Wollinsky, Kurt
- Ludolph, Albert C.
- Deschauer, Marcus
- Lingor, Paul
- Tumani, Hayrettin
- Hermann, Andreas
- Günther, René
- Wurster, Claudia D.
- Universität Ulm
Time of origin
- 2019
Other Objects (12)
Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy
Cathepsin D as biomarker in CSF of nusinersen‐treated patients with spinal muscular atrophy
Spinal muscular atrophy
CSF IL-8 Associated with Response to Gene Therapy in a Case Series of Spinal Muscular Atrophy
Choosing Life with Spinal Muscular Atrophy Type 1
Growth patterns in children with spinal muscular atrophy
Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia
Altered cerebrospinal fluid (CSF) in children with ataxia telangiectasia
Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy
Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment
J wave syndromes in patients with spinal and bulbar muscular atrophy
Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy
Cathepsin D as biomarker in CSF of nusinersen‐treated patients with spinal muscular atrophy
Spinal muscular atrophy
CSF IL-8 Associated with Response to Gene Therapy in a Case Series of Spinal Muscular Atrophy
Choosing Life with Spinal Muscular Atrophy Type 1
Growth patterns in children with spinal muscular atrophy
Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia
Altered cerebrospinal fluid (CSF) in children with ataxia telangiectasia
Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy
Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment
J wave syndromes in patients with spinal and bulbar muscular atrophy
Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy
Cathepsin D as biomarker in CSF of nusinersen‐treated patients with spinal muscular atrophy
Spinal muscular atrophy
CSF IL-8 Associated with Response to Gene Therapy in a Case Series of Spinal Muscular Atrophy
Choosing Life with Spinal Muscular Atrophy Type 1
Growth patterns in children with spinal muscular atrophy
Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia
Altered cerebrospinal fluid (CSF) in children with ataxia telangiectasia
Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy
Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment